Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06164613 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Cinnamomum Verum for Induction of Labor. Double Blind Randomized Clinical Trial

Study acronym: CINNALAB
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 32 to 70v6
  2. Primary completion date: Sep 30, 2024 to Dec 30, 2026
    • Study completion date: Oct 30, 2024 to Dec 30, 2026
    v5
  3. Study title expanded, about 5 wordsv4
  4. Primary completion date: Mar 31, 2024 to Sep 30, 2024
    • Study completion date: Jun 30, 2024 to Oct 30, 2024
    v3
  5. Secondary endpoints: details revised at 4 of 4 entries
    • Study title shortened, about 4 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the research protocol is to evaluate the effectiveness of Cinnamomum verum extract for the initiation of labor. Cinnamaldehyde ((E)-3-Phenylprop-2-enal) is an α, β unsaturated aromatic aldehyde, derived from cinnamon (Cinnamomum Verum oil) used as a flavoring; It is a clear yellowish liquid substance, with a strong odor and flavor. It is the main component of cinnamon (63%), giving it its physicochemical properties. Cinnamon has been an element of empirical use for the beginning of labor, however, its effectiveness has not been demonstrated. Cinnamon has been reported for its ethnopharmacological properties in pregnancy, being used to facilitate childbirth, as a lactagogue and for postpartum recovery. In Honduras, its use has been reported to relieve nausea and vomiting during pregnancy, to reduce abdominal pain. , reduction of lower limb edema, to relieve anxiety during labor, as well as a lactagogue without convergent opinions.
Trial Details
NCT Number NCT06164613
Lead Sponsor Universidad Nacional Autonoma de Honduras
Conditions
(from sponsor)		 Labor Onset and Length Abnormalities, First Birth
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov